Micropapillary bladder cancer: Current treatment patterns and review of the literature

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 6, 2014, Pages 826-832

  Willis, Daniel L ^a   Flaig, Thomas W ^b   Hansel, Donna E ^c   Milowsky, Matthew I ^d   Grubb, Robert L ^e   Al Ahmadie, Hikmat A ^f   Plimack, Elizabeth R ^g   Koppie, Theresa M ^h   McConkey, David J ^a   Dinney, Colin P ^a   Hoffman, Vanessa A ⁱ   Droller, Michael J ^j   Messing, Edward ^k   Kamat, Ashish M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ Bladder Cancer Advocacy Network   (United States)

^j MOUNT SINAI HOSPITAL   (United States)

^k UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

Bladder cancer; Micropapillary; Review; Survey

Indexed keywords

CISPLATIN;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CYSTECTOMY; DISEASE SPECIFIC SURVIVAL; FOLLOW UP; HEALTH SURVEY; HUMAN; HYDRONEPHROSIS; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MEDICAL ONCOLOGIST; MICROPAPILLARY BLADDER CANCER; MULTIMODALITY CANCER THERAPY; PATHOLOGIST; PRIORITY JOURNAL; RADIATION ONCOLOGIST; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UROLOGIST; ADJUVANT CHEMOTHERAPY; CARCINOMA, TRANSITIONAL CELL; CLINICAL PRACTICE; NEOADJUVANT THERAPY; ONCOLOGY; PATHOLOGY; PROCEDURES; RADIOTHERAPY; STATISTICS AND NUMERICAL DATA; URINARY BLADDER NEOPLASMS;

CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; HUMANS; MEDICAL ONCOLOGY; NEOADJUVANT THERAPY; PRACTICE PATTERNS, PHYSICIANS'; RADIOTHERAPY; URINARY BLADDER NEOPLASMS;

EID: 84905282023     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.01.020     Document Type: Article

References (32)

1. Amin M.B., Ro J.Y., el-Sharkawy T., et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994, 18:1224-1232.
2. Watts K.E., Hansel D.E. Emerging concepts in micropapillary urothelial carcinoma. Adv Anat Pathol 2010, 17:182-186.
3. Holmang S., Thomsen J., Johansson S.L. Micropapillary carcinoma of the renal pelvis and ureter. J Urol 2006, 175:463-466. [discussion 466-7].
4. Johansson S.L., Borghede G., Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol 1999, 161:1798-1802.
5. Alvarado-Cabrero I., Sierra-Santiesteban F.I., Mantilla-Morales A., et al. Micropapillary carcinoma of the urothelial tract. A clinicopathologic study of 38 cases. Ann Diagn Pathol 2005, 9:1-5.
6. Baschinsky D.Y., Chen J.H., Vadmal M.S., et al. Carcinosarcoma of the urinary bladder-an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literature. Arch Pathol Lab Med 2000, 124:1172-1178.
7. Samaratunga H., Khoo K. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 2004, 45:55-64.
8. Kamat A.M., Gee J.R., Dinney C.P., et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 2006, 175:881-885.
9. Kamat A.M., Dinney C.P., Gee J.R., et al. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 2007, 110:62-67.
10. Ghoneim I.A., Miocinovic R., Stephenson A.J., et al. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology 2011, 77:867-870.
11. Comperat E., Roupret M., Yaxley J., et al. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology 2010, 42:650-654.
12. Fairey A.S., Daneshmand S., Wang L., et al. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol 2014, 32:110-116.
13. Wang J.K., Boorjian S.A., Cheville J.C., et al. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis. World J Urol 2012, 30:801-806.
14. Meeks J.J., Taylor J.M., Matsushita K., et al. Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU Int 2013, 111:325-330.
15. Gaya J.M., Palou J., Algaba F., et al. The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ. Can J Urol 2010, 17:5370-5376.
16. Bladder Cancer Advocacy Network, [accessed 23.03.13.]. http://www.bcan.org/medical/think-tank/.
17. Survey Monkey, [accessed 01.12.12.]. http://www.surveymonkey.com/.
18. Abd El-Latif A., Watts K.E., Elson P., et al. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. J Urol 2012, 189:1263-1267.
19. Hansel D.E., Amin M.B., Comperat E., et al. A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. Eur Urol 2013, 63:321-332.
20. Sangoi A.R., Beck A.H., Amin M.B., et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 2010, 34:1367-1376.
21. Shah R.B., Montgomery J.S., Montie J.E., et al. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. Urol Oncol 2013, 31:1650-1655.
22. Maranchie J.K., Bouyounes B.T., Zhang P.L., et al. Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant. J Urol 2000, 163:748-751.
23. Sangoi A.R., Higgins J.P., Rouse R.V., et al. Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact. Mod Pathol 2009, 22:660-667.
24. Alkibay T., Sozen S., Gurocak S., et al. Micropapillary pattern in urothelial carcinoma: a clinicopathological analysis. Urol Int 2009, 83:300-305.
25. Vourganti S., Harbin A., Singer E.A., et al. Low grade micropapillary urothelial carcinoma, does it exist?-analysis of management and outcomes from the Surveillance, Epidemiology and End Results (SEER) database. J Cancer 2013, 4:336-342.
26. Amin A., Epstein J.I. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases. Hum Pathol 2012, 43:2124-2128.
27. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859-866.
28. Lobiondo-Wood G., Brown C.G., Knobf M.T., et al. Priorities for oncology nursing research: the 2013 national survey. Oncol Nurs Forum 2014, 41:67-76.
29. Vadaparampil S.T., Murphy D., Rodriguez M., et al. Qualitative responses to a national physician survey on HPV vaccination. Vaccine 2013, 31:2267-2272.
30. Rocke D.J., Thomas S., Puscas L., et al. Physician knowledge of and attitudes toward the Patient Protection and Affordable Care Act. Otolaryngol Head Neck Surg 2014, 150:229-234.
31. Sahlqvist S., Song Y., Bull F., et al. Effect of questionnaire length, personalisation and reminder type on response rate to a complex postal survey: randomised controlled trial. BMC Med Res Methodol 2011, 11:62.
32. Grava-Gubins I., Scott S. Effects of various methodologic strategies: survey response rates among Canadian physicians and physicians-in-training. Can Fam Physician 2008, 54:1424-1430.